On 12 MAY Flamel Technologies S.A. (ADR) (NASDAQ:FLML) reported total revenues during the first quarter of 2014 of $9.2 million, which reflected the initial recognition of sales of Bloxiverz, compared to $5.1 million in the first quarter of 2013, an increase of 78.5% compared to the year-ago period. Product sales and services revenues in the first quarter of 2014 of were $5.9 million, compared to $2.1 million in the prior year quarter as the Company continues its successful transition from a drug delivery company to a self-funded specialty pharmaceutical company. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) weekly performance is -2.40%. On last trading day company shares ended up $10.16. Analysts mean target price for the company is $20.95. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) distance from 50-day simple moving average (SMA50) is -15.01%.
On 20 MAY IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) announced that it has filed a preliminary short form base shelf prospectus with securities regulatory authorities in each of the provinces and territories of Canada, except Quebec, and filed a registration statement with the United States Securities and Exchange Commission on Form F-3. IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) ended the day on $3.76. IPCI return on assets is -139.80%.IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) quarterly performance is 1.35%.
On 23 MAY Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) reported ($0.08) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.05) by $0.03. Analysts expect that Acura Pharmaceuticals will post $-0.16 EPS for the current fiscal year. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) shares moved down -0.81% in last trading session and was closed at $1.23, while trading in range of $1.22 – $1.26. Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) year to date (YTD) performance is -26.35%.
On 7 MAY Delcath Systems, Inc. (NASDAQ:DCTH) reported financial results and corporate developments for the fiscal first quarter ended March 31, 2014. For the first quarter ended March 31, 2014, total product revenue was $0.3 million compared with total product revenue of approximately $0.1 million in the first quarter 2013. Operating expenses decreased by approximately 50% to $5.3 million from $10.6 million for the same period in 2013. Delcath Systems, Inc. (NASDAQ:DCTH) ended the last trading day at $2.65. Company weekly volatility is calculated as 7.54% and price to cash ratio as 0.80. Delcath Systems, Inc. (NASDAQ:DCTH) showed a negative weekly performance of -2.57%
Petmed Express Inc (NASDAQ:PETS) ‘s earnings per share (EPS) of 23 cents in the fourth quarter of fiscal 2014 came in 2 cents ahead of the Zacks Consensus Estimate. However, the number remained unchanged year over year. For the full year, EPS came in at 90 cents, up 4.7% from the prior-year quarter. Petmed Express Inc (NASDAQ:PETS) net profit margin is 9.70% and weekly performance is 0.30%. On last trading day company shares ended up $13.39. Analysts mean target price for the company is $14.00. Petmed Express Inc (NASDAQ:PETS) distance from 50-day simple moving average (SMA50) is 3.33%.